Startseite
Reels
Gruppen
Seiten
Mehr sehen
Gruppen Seiten Veranstaltungen Blogs Angebote Jobs Gruppen Foren Filme Spiele
Anmelden Registrieren
Nachtmodus
Why Monoclonal Antibodies Lead the Oncology Biosimilars Market
Monoclonal antibodies have transformed cancer treatment by targeting specific proteins and pathways involved in tumor growth or immune regulation. As the patents of major biologic medicines expire, biosimilar versions are creating new competition in oncology. The Oncology Biosimilars Market is forecast to grow from USD 5.469 billion in 2024 to USD 14.4 billion by 2035. Monoclonal antibodies...
0 Kommentare ·0 Geteilt ·226 Ansichten ·0 Bewertungen
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!